Department of Vascular Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK -
Vascular Endovascular and Transplant Surgery, Christchurch Public Hospital, Canterbury, New Zealand.
Int Angiol. 2022 Apr;41(2):118-127. doi: 10.23736/S0392-9590.22.04799-X. Epub 2022 Feb 3.
Percutaneous endovascular aneurysm repair (PEVAR) is becoming increasingly popular due to fewer access-related complications, shorter procedural times and length of stay (LOS). Our aim was to explore factors associated with access-related complications and their impact on procedural time and LOS.
We retrospectively analyzed consecutive aorto-iliac endovascular procedures in a tertiary hub comprising 2 institutions and 18 consultant vascular surgeons and interventional radiologists between 2016-2017. Access-related complications were defined as: bleeding requiring cutdown or return to theatre, acute limb ischemia or common femoral artery (CFA) pseudoaneurysm requiring intervention and wound infection or dehiscence needing hospitalization.
Of 511 patients, 354 (69%) had a percutaneous approach via 589 CFA access sites. In this percutaneous group, access-related complications occurred in 11% of sites (65/589); Their rate varied with procedure type ranging between 3.6% to 17.6%. The most common complication was bleeding due to closure device failure in 8.5% (50/589) of access sites. When uncomplicated, percutaneous interventions were faster compared to open surgical access (P<0.0001). Operation time and median LOS (3 vs. 2 days) were longer for elective standard EVAR patients experiencing access-related complications (P=0.033). In the percutaneous group, multivariate regression analysis demonstrated significant associations between access-related complications and eGFR (odds ratio (OR) 0.984 [0.972-0.997], P=0.014), CFA depth (OR 1.026 [1.008-1.045], P=0.005), device used (Prostar vs. Proglide (OR 2.177 [1.236-3.832], P=0.007) and procedural type (complex vs. standard EVAR) (OR 2.017 [1.122-3.627], P=0.019). We developed a risk score which had reasonably good predictive power (C-statistic 0.716 [0.646-0.787], P<0.0001) for avoiding access complications.
Physiological (low eGFR level), anatomical (increased CFA depth) and technical factors (choice of device and complex procedures) were identified as predictors of access-related complications in this large retrospective series. These are important for safe selection of patients that would benefit from percutaneous access.
由于与入路相关的并发症较少、手术时间和住院时间(LOS)较短,经皮血管内腹主动脉瘤修复术(PEVAR)越来越受欢迎。我们的目的是探讨与入路相关的并发症及其对手术时间和 LOS 的影响相关的因素。
我们回顾性分析了 2016-2017 年间在一个由 2 家机构和 18 名顾问血管外科医生和介入放射科医生组成的三级中心进行的连续腹主动脉-髂血管腔内手术。与入路相关的并发症定义为:需要切开或返回手术室的出血、急性肢体缺血或股总动脉(CFA)假性动脉瘤需要干预以及需要住院治疗的伤口感染或裂开。
在 511 例患者中,354 例(69%)通过 589 个 CFA 入路进行经皮入路。在经皮组中,11%(65/589)的入路部位发生与入路相关的并发症;其发生率因手术类型而异,范围为 3%至 17.6%。最常见的并发症是由于闭合装置故障导致的出血,占 589 个入路部位的 8.5%(50/589)。在无并发症的情况下,与开放手术入路相比,经皮介入治疗速度更快(P<0.0001)。对于经历与入路相关并发症的择期标准 EVAR 患者,手术时间和中位 LOS(3 天与 2 天)较长(P=0.033)。在经皮组中,多变量回归分析显示,与入路相关的并发症与 eGFR(比值比(OR)0.984 [0.972-0.997],P=0.014)、股总动脉深度(OR 1.026 [1.008-1.045],P=0.005)、使用的装置(Prostar 与 Proglide(OR 2.177 [1.236-3.832],P=0.007)和手术类型(复杂与标准 EVAR)(OR 2.017 [1.122-3.627],P=0.019)显著相关。我们开发了一种风险评分,该评分具有相当好的预测能力(C 统计量 0.716 [0.646-0.787],P<0.0001),可避免入路并发症。
在这项大型回顾性研究中,生理(低 eGFR 水平)、解剖(股总动脉深度增加)和技术因素(装置选择和复杂手术)被确定为与入路相关并发症相关的预测因素。这些因素对于安全选择将从经皮入路中受益的患者很重要。